Pictor Holdings Inc., a global targeted proteomic platform company, highlighted the publication of an independent peer-reviewed study conducted by researchers at Texas A&M University and published in Frontiers in Veterinary Science evaluating the Pictor PictVet® assay for monitoring anti-Mycoplasma bovis (M. bovis) IgG antibodies in bovine nasopharyngeal swabs.
